Home » Topics » BioWorld Science

BioWorld Science
RSS

Enrollment ongoing in phase III study of pertuzumab and trastuzumab fixed-dose combination

June 7, 2018

GlaxoSmithKline initiates phase I study of GSK-3858279

June 7, 2018

Phase II results presented for TAK-954 in patients with enteral feeding intolerance

June 7, 2018

Athersys expands its collaboration with Healios

June 7, 2018

EMA grants PRIME designation for dilanubicel

June 7, 2018

FDA grants orphan drug designation to TransCon PTH

June 7, 2018

4D pharma and MSD collaborate to study Keytruda and MRx-0518 combination in solid tumors

June 7, 2018

Positive results presented from ongoing phase I trial of PTI-801 in patients with CF

June 7, 2018

First healthy volunteers enrolled in phase I study of BTRX-335140

June 7, 2018

ROR-1-targeting cirmtuzumab inhibits stemness signatures in phase I trial in CLL patients

June 7, 2018

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...